Creatinine Clearance as a Predictor of Successful Withdrawl of Continuous Renal Replacement Therapy in Intensive Care
STOP EERc
1 other identifier
observational
64
1 country
1
Brief Summary
Acute renal failure is a common complication in patients admitted to intensive care. Due to the increasing incidence of acute renal failure, the use of Continuous Renal Replacement Therapy (CRRT) is on the rise in the intensive care unit. The use of CRRT exposes patients to some complications (bleeding, hemodynamic instability, antibiotic underdosing, malnutrition and infections), justifying the importance of optimizing the quality and reliability of this technique. Renal function is classically assessed by diuresis and creatinine. Creatinine clearance is an indirect measure of glomerular filtration rate. Measuring creatinine clearance is a simple, accessible and relatively inexpensive method. Traditionally, clreatinine clearance has required 24-hour urine collection. However, it has been shown that two-hour urine collection is also an accurate tool. There is little information and few recommendations as to when to discontinue CRRT. A predictive index for the withdrawal of CRRT would reduce the duration of treatment, reduce complications and costs, and speed up patient rehabilitation. Various parameters have been described as tools for deciding when to stop dialysis: diuresis before stopping CRRT, urine and blood creatinine, daily urinary urea excretion, and sodium and water balance. Among these factors, urine output and creatinine appear to be promising predictive factors. The measurement of creatinine clearance combines these two factors and can therefore be a good tool for predicting the return of adequate renal function. Retrospective work carried out by Fröhlich et al in 2012 suggested that creatinine clearance measured over 2 hours could be a good marker for successful withdrawal. The hypothesis of the study is that creatinine clearance measured over 2 hours after stopping CRRT is be predictive of the success of the withdrawal from this type of therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
April 27, 2020
CompletedFirst Posted
Study publicly available on registry
May 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2021
CompletedJune 2, 2021
May 1, 2021
2.5 years
April 27, 2020
May 31, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
creatinine clearance over 2 hours
Through study completion, an average of 2 hours
Interventions
To measure the clearance of creatinine, urea, potassium, magnesium, sodium, chlorine...
Eligibility Criteria
Inpatients in intensive care
You may qualify if:
- Dialysis for AKI with minimum 12 hours of continuous renal replacement therapy (CVVH-CVVHD)
- Patient in whom dialysis withdrawal is being considered
- Patients over 18 years of age
You may not qualify if:
- Pre-existing chronic end-stage renal failure on chronic dialysis
- Extrarenal purification during hospitalization prior to admission to intensive care unit
- Inability to assess the primary outcome
- Kidney Transplantation
- Pregnant Women
- Person not affiliated to a national health insurance
- Decision to limit or stop therapy
- Isolated hyperkalemia
- Refusal of patient participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Dijon Bourgogne
Dijon, 21000, France
Biospecimen
Urine
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2020
First Posted
May 5, 2020
Study Start
October 1, 2018
Primary Completion
March 30, 2021
Study Completion
March 30, 2021
Last Updated
June 2, 2021
Record last verified: 2021-05